The use of SSTR2-induced cytotoxic effect and Notch signalling regulator valproic acid has been proposed in combination as a potential therapeutic intervention in SCLC by suppressing tumour growth and increasing SSTR2 expression. The gene discussed is SSTR2; the disease is neoplasm.